{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "GIP and GLP-1 co-agonist compounds", "item": "https://www.patentleaderboard.com/patent/9474780"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GIP and GLP-1 co-agonist compounds

GIP and GLP-1 co-agonist compounds

US Patent 9474780 · Granted Oct 25, 2016

Estimated economic value: $390,705,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using and compositions including an incretin analog2025
Method of using a GIP/GLP1 co-agonist for diabetes2025
Method of using a GIP/GLP1 co-agonist for diabetes2025
Incretin analogs and uses thereof2025
Incretin analogs and uses thereof2025
Model based dynamic positional correction for digital lithography tools2025
Incretin analogs and uses thereof2025
Incretin analogs and uses thereof2025
Deep learning based adaptive alignment precision metrology for digital overlay2025
Incretin analogs and uses thereof2025
Incretin analogs and uses thereof2025
Method of using a GIP/GLP1 co-agonist for diabetes2025